NEOPLASM
Clinical trials for NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new NEOPLASM trials appear
Sign up with your email to follow new studies for NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New weapon tested against Tough-to-Treat cancers
Disease control TerminatedThis early-stage study tested a new drug called SAR443216 in people with advanced solid tumors that have a protein called HER2 and have stopped responding to other treatments. The main goals were to find a safe dose and see how the body processes the drug. Researchers also looked…
Matched conditions: NEOPLASM
Phase: PHASE1 • Sponsor: Sanofi • Aim: Disease control
Last updated Apr 01, 2026 21:26 UTC
-
First patients test new hope for Tough-to-Treat cancers
Disease control TerminatedThis early-stage study tested a new drug called SAR444200, given alone or with other cancer treatments, in adults with advanced solid tumors that had progressed after standard care. The main goals were to find a safe dose and see if the drug showed any signs of fighting the cance…
Matched conditions: NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC